Patent · US Active

Modified nanopores, compositions comprising the same, and uses thereof

US10976300B2 · kind B2 · utility

20Cited by
34References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 2016
Grant dateApr 13, 2021
Priority date
Expiry dateFeb 5, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6869
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided herein relate to modified or mutant forms of cytolysin A (ClyA) and compositions comprising the same. In particular, the modified or mutant forms of ClyA permits efficient capture and/or translocation of a target negative-charged molecule or polymer through the modified or mutant ClyA nanopores at low or physiological ionic strengths. Thus, methods for using the modified or mutant forms of ClyA and compositions, for example, for characterizing a target negatively-charged analyte, e.g., a target polynucleotide, are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.